Literature DB >> 21843977

DNA damage response, genetic instability and cancer: from mechanistic insights to personalized treatment.

Jiri Bartek.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21843977      PMCID： PMC5528317          DOI： 10.1016/j.molonc.2011.07.006

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


× No keyword cloud information.
  34 in total

1.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.

Authors:  Raffaella Di Micco; Marzia Fumagalli; Angelo Cicalese; Sara Piccinin; Patrizia Gasparini; Chiara Luise; Catherine Schurra; Massimiliano Garre'; Paolo Giovanni Nuciforo; Aaron Bensimon; Roberta Maestro; Pier Giuseppe Pelicci; Fabrizio d'Adda di Fagagna
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

2.  DNA damage response, genetic instability and cancer: from mechanistic insights to personalized treatment.

Authors:  Jiri Bartek
Journal:  Mol Oncol       Date:  2011-07-22       Impact factor: 6.603

Review 3.  Transcriptional modulation induced by ionizing radiation: p53 remains a central player.

Authors:  Sharon Rashi-Elkeles; Ran Elkon; Seagull Shavit; Yaniv Lerenthal; Chaim Linhart; Ana Kupershtein; Ninette Amariglio; Gideon Rechavi; Ron Shamir; Yosef Shiloh
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

4.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 5.  Chromatin and the DNA damage response: the cancer connection.

Authors:  Martijn S Luijsterburg; Haico van Attikum
Journal:  Mol Oncol       Date:  2011-07-03       Impact factor: 6.603

6.  The combined status of ATM and p53 link tumor development with therapeutic response.

Authors:  Hai Jiang; H Christian Reinhardt; Jirina Bartkova; Johanna Tommiska; Carl Blomqvist; Heli Nevanlinna; Jiri Bartek; Michael B Yaffe; Michael T Hemann
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

Review 7.  DNA damage signalling guards against activated oncogenes and tumour progression.

Authors:  J Bartek; J Bartkova; J Lukas
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

8.  Replication stress induces 53BP1-containing OPT domains in G1 cells.

Authors:  Jeanine A Harrigan; Rimma Belotserkovskaya; Julia Coates; Daniela S Dimitrova; Sophie E Polo; Charles R Bradshaw; Peter Fraser; Stephen P Jackson
Journal:  J Cell Biol       Date:  2011-03-28       Impact factor: 10.539

9.  Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Authors:  Peter C Fong; David S Boss; Timothy A Yap; Andrew Tutt; Peijun Wu; Marja Mergui-Roelvink; Peter Mortimer; Helen Swaisland; Alan Lau; Mark J O'Connor; Alan Ashworth; James Carmichael; Stan B Kaye; Jan H M Schellens; Johann S de Bono
Journal:  N Engl J Med       Date:  2009-06-24       Impact factor: 91.245

10.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors:  Hannah Farmer; Nuala McCabe; Christopher J Lord; Andrew N J Tutt; Damian A Johnson; Tobias B Richardson; Manuela Santarosa; Krystyna J Dillon; Ian Hickson; Charlotte Knights; Niall M B Martin; Stephen P Jackson; Graeme C M Smith; Alan Ashworth
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504
View more
  15 in total

1.  Modeling study of dose-response relationships for radiation-induced chromosomal instability.

Authors:  S G Andreev; Ya A Eidelman; I V Salnikov; S V Slanina
Journal:  Dokl Biochem Biophys       Date:  2013-08-23       Impact factor: 0.788

2.  DNA damage response, genetic instability and cancer: from mechanistic insights to personalized treatment.

Authors:  Jiri Bartek
Journal:  Mol Oncol       Date:  2011-07-22       Impact factor: 6.603

3.  Fastest time to cancer by loss of tumor suppressor genes.

Authors:  Cynthia Sanchez-Tapia; Frederic Y M Wan
Journal:  Bull Math Biol       Date:  2014-10-23       Impact factor: 1.758

4.  SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.

Authors:  H Yin; C Qin; Y Zhao; Y Du; Z Sheng; Q Wang; Q Song; L Chen; C Liu; T Xu
Journal:  Clin Transl Oncol       Date:  2017-03-03       Impact factor: 3.405

5.  Wls promotes the proliferation of breast cancer cells via Wnt signaling.

Authors:  Dong Lu; Ying Li; Qing-Ru Liu; Qi Wu; Hao Zhang; Peng Xie; Qingling Wang
Journal:  Med Oncol       Date:  2015-03-24       Impact factor: 3.064

6.  Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene.

Authors:  Jeeyun Lee; Chang Ohk Sung; Eui J Lee; In-Gu Do; Hee-Cheol Kim; Seong Hyeon Yoon; Woo Yong Lee; Ho Kyung Chun; Kyoung-Mee Kim; Young Suk Park
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

7.  ROS-induced cell cycle arrest as a mechanism of resistance in polyaneuploid cancer cells (PACCs).

Authors:  Morgan D Kuczler; Athen M Olseen; Kenneth J Pienta; Sarah R Amend
Journal:  Prog Biophys Mol Biol       Date:  2021-05-12       Impact factor: 4.799

8.  Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.

Authors:  Xinghua Li; Weijiang Liang; Junling Liu; Chuyong Lin; Shu Wu; Libing Song; Zhongyu Yuan
Journal:  Breast Cancer Res       Date:  2014-10-24       Impact factor: 6.466

9.  GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.

Authors:  Qing Zhang; Junlong Zhuang; Yongming Deng; Xiaozhi Zhao; Bo Tang; Dongwei Yao; Wei Zhao; Cunjie Chang; Qun Lu; Wei Chen; Shiwei Zhang; Changwei Ji; Lin Cao; Hongqian Guo
Journal:  Oncotarget       Date:  2015-10-13

10.  Anticancer Activity and Apoptosis Induction of Gold(III) Complexes Containing 2,2'-Bipyridine-3,3'-dicarboxylic Acid and Dithiocarbamates.

Authors:  Ali Alhoshani; Adam A A Sulaiman; Homood M As Sobeai; Wajhul Qamar; Moureq Alotaibi; Khalid Alhazzani; Muhammad Monim-Ul-Mehboob; Saeed Ahmad; Anvarhusein A Isab
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.